Calls Now Open
2024 ADDF-Harrington + 2025 Harrington Scholar-Innovator Programs
April 16, 2024
Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2024 class of Harrington Scholar-Innovators. The scholar awards will support breakthrough new treatments for heart disease, autoimmune disorders, cancer, infectious disease, inflammation, and rare diseases using small molecule...
Continue ReadingMarch 02, 2021
Cleveland, Ohio – Harrington Discovery Institute at University Hospitals and the Alzheimer's Drug Discovery Foundation (ADDF) announce a joint request for proposals for the . The ADDF-Harrington Scholar Award is designed to accelerate the translation of innovative research that could treat, prevent, or slow Alzheimer's... Continue Reading
February 18, 2021
CLEVELAND, OH—The transatlantic, not-for-profit medical accelerator, Harrington Discovery Institute at University Hospitals, has collaborated with leading venture investor, Advent Life Sciences (‘Advent’) in the launch of the Advent-Harrington Impact Fund.Advent’s new impact fund, structured alongside Advent Life... Continue Reading
November 10, 2020
Cleveland, Ohio, USA – Harrington Discovery Institute at University Hospitals and Case Western Reserve University School of Medicine have issued a call for proposals for the 2021 Harrington-MSTP (Medical Scientist Training Program) Scholar Award to help the next generation of physician-scientists advance their discoveries... Continue Reading
October 23, 2020
CLEVELAND — Traumatic brain injury (TBI) is a leading cause of cognitive impairment that affects millions of people worldwide. Despite growing awareness about the debilitating and lifelong progressive consequences of TBI, there are currently no treatments that slow the deteriorative process. TBI survivors are currently... Continue Reading
October 14, 2020
October 14, 2020, CLEVELAND, Ohio USA – The Harrington Discovery Institute® at University Hospitals in Cleveland, Ohio, and its registered charity Fund for Cures UK, Ltd., together with Morgan Stanley GIFT (Global Impact Funding Trust) Cures, announced five winners in the inaugural Harrington UK Rare Disease Scholar Award... Continue Reading
August 10, 2020
As novel coronavirus cases continue to increase in the United States and throughout the world, the , in collaboration with , is raising funds for research to bring an end to the COVID-19 pandemic.Officials confirm the money will support Harrington’s COVID-19 Rapid Response Initiative to provide critical funding to selected... Continue Reading
July 21, 2020
New York/Cleveland, OH, July 21, 2020 – A licensing agreement between drug maker Acadia Pharmaceuticals and Vanderbilt University represents a major milestone for the ADDF-Harrington Scholar Award Program, which provided funding and pharmaceutical expertise to support the research in the early phases. Acadia and Vanderbilt... Continue Reading
July 15, 2020
July 15, 2020, CLEVELAND, Ohio USA – National and international nominations are being sought for the 2021 Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application. The deadline... Continue Reading
July 08, 2020
NEW YORK, NY, July 8, 2020 – The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals have granted , of Mayo Clinic Rochester, an .Dr. Trushina has been awarded $600,000 for her late stage preclinical research on new drug candidates that show promise in restoring... Continue Reading
July 08, 2020
July 8, 2020, CLEVELAND and NEW YORK CITY – Coronavirus cases continue to increase in the United States and throughout the world. Harrington Discovery Institute at University Hospitals, in collaboration with Morgan Stanley GIFT (Global Impact Funding Trust) Cures, is raising funds for research to bring an end to the COVID-19... Continue Reading